Dr
Pinar UlugProfile page
Honorary Research Fellow
Department of Surgery & Cancer - Faculty of Medicine
Orcid identifier0000-0001-9719-1090
- Honorary Research FellowDepartment of Surgery & Cancer - Faculty of Medicine
- 020 3311 7307 (Work)
- North Wing - 4N12, Charing Cross Hospital, Charing Cross Campus, United Kingdom
BIO
Dr Ulug completed her BSc in Biological Sciences with French at the University of Rochester, New York in 2003 as a Fulbright/ CASP (Cyprus-America Scholarship Program) Scholar and subsequently an MSc in Molecular Biology at the University of Wales, Cardiff. She then completed her PhD in Molecular Haematology at King’s College London, with the support of an MRC-funded studentship at Professor Swee Lay Thein’s laboratory, investigating potential markers of disease severity in patients with sickle cell disease. After working as a Postdoctoral Researcher at Queen Mary, University of London, she joined the Vascular Surgery Research Group at Imperial College London in 2009 as Clinical Trial Manager and coordinated and managed the IMPROVE trial (multi-centre, emergency surgery randomised controlled trial supported by the NIHR HTA programme), which reported final results in 2017. Dr Ulug has also worked on a project involving individual patient data meta-analysis of EVAR-1, DREAM, OVER and ACE randomised controlled trials that compared elective endovascular and open repair of abdominal aortic aneurysm (a very large pool of world first randomised data from four countries). She has experience of working with Hospital Episode Statistics (HES) data extracts, in particular cleaning the data to improve validity. Most recently, Dr Ulug worked in collaboration with specialists in vascular surgery, AAA epidemiology, medical statistics and health economics, from the Universities of Cambridge, Leicester and Brunel on another UK Department of Health funded project to assess the feasibility of population screening in women, which reported results in 2018.
Since 2019, Dr Ulug has been working on the British Society of Endovascular Therapy -ConformabLe EndoVascular Aneurysm Repair (BSET-CLEVAR) Registry, which involves 19 NHS hospitals in the UK.
recent awards:
Frank Lederle Prize at the 6th International Meeting on Aortic Diseases (2018) for best short communication on epidemiology and natural history of abdominal aortic aneurysm (Abstract title: "Should we screen women for abdominal aortic aneurysm?").
Raymond Limet Special Prize at International Meeting on Aortic Diseases (IMAD) 2016 for the presentation of “Meta-analysis of the current prevalence of screen-detected abdominal aortic aneurysm in women”.
Since 2019, Dr Ulug has been working on the British Society of Endovascular Therapy -ConformabLe EndoVascular Aneurysm Repair (BSET-CLEVAR) Registry, which involves 19 NHS hospitals in the UK.
recent awards:
Frank Lederle Prize at the 6th International Meeting on Aortic Diseases (2018) for best short communication on epidemiology and natural history of abdominal aortic aneurysm (Abstract title: "Should we screen women for abdominal aortic aneurysm?").
Raymond Limet Special Prize at International Meeting on Aortic Diseases (IMAD) 2016 for the presentation of “Meta-analysis of the current prevalence of screen-detected abdominal aortic aneurysm in women”.
FACULTY
- Faculty of Medicine
POSITION NAME
- Honorary Research Fellow